These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35422944)

  • 21. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
    J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and development of dry powder sulfobutylether-β-cyclodextrin complex for pulmonary delivery of fisetin.
    Mohtar N; Taylor KM; Sheikh K; Somavarapu S
    Eur J Pharm Biopharm; 2017 Apr; 113():1-10. PubMed ID: 27916704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
    Jarho P; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications.
    Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC
    Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
    Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
    Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of sulfobutylether β-cyclodextrin-silica hybrid monolithic column, and its application to capillary electrochromatography of chiral compounds.
    Zhou L; Liu B; Guan J; Jiang Z; Guo X
    J Chromatogr A; 2020 Jun; 1620():460932. PubMed ID: 32029266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether beta-cyclodextrins (SBE) and danazol-SBE inclusion complexes.
    Jain AC; Adeyeye MC
    Int J Pharm; 2001 Jan; 212(2):177-86. PubMed ID: 11165075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preparation, characterization and antitumor of cyclodextrin inclusion of an anti-cancer drug regorafenib].
    Kai-Hang L; Mengying S; Guping T; Xiurong HU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):144-152. PubMed ID: 28752706
    [No Abstract]   [Full Text] [Related]  

  • 33. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermosensitive
    Gözcü S; Polat KH
    Turk J Pharm Sci; 2023 May; 20(2):78-83. PubMed ID: 37161283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propyl gallate/cyclodextrin supramolecular complexes with enhanced solubility and radical scavenging capacity.
    Li Q; Pu H; Tang P; Tang B; Sun Q; Li H
    Food Chem; 2018 Apr; 245():1062-1069. PubMed ID: 29287323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S; Agrawal GP
    Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
    Pillai K; Akhter J; Morris DL
    J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.